For model organisms, the shortest delivery time is 3 weeks. We also offer cost-effective plans and DNBseq sequencing contract services.
RNA-seq is one of the next-generation sequencing analyses, a method for comprehensively detecting gene expression known as the transcriptome. It can accommodate various species and allows for the analysis of gene and transcript expression levels as well as splicing patterns. For model organisms, results can be delivered in as little as 3 to 4 weeks. A data confirmation guide (a booklet) is included with the delivery, making it reassuring for beginners. 【Features】 - We offer cost-effective plans and DNBseq sequencing contract services. - Identification of novel transcripts. - Total RNA starting from 1μg or 10ng is possible. - Proven results with various species, including model organisms (humans, mice, plants, fish, frogs, yeast, bacteria, etc.). *We are currently offering a booklet that clearly introduces the principles and benefits. You can view it immediately via "PDF download."
Inquire About This Product
basic information
【Contracted Service Contents】 ■Total RNA Quality Inspection ■Library Preparation ■Sequencing ■Data Analysis ■Delivery via USB/HDD, including analysis report and "Guidebook" 【What is the Guidebook?】 Friendly for those new to RNA-seq analysis, please use it as a guide when reviewing analysis data. A PDF file consisting of approximately 50 pages is included on the USB/HDD. - Folder structure and how to view each file on the USB/HDD - Introduction to free web tools for enrichment analysis such as IGV and GSEA - Glossary of terms - Example materials for papers, etc. 【Types of Guidebooks】 Included with delivery according to the NGS analysis lineup. - RNA-seq - CAGE-seq - ATAC-seq/CHIP-seq - WGS/WES - Data registration to GEO - Enrichment analysis
Price range
P2
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（8）
Download All Catalogs
Company information
Danaform Inc. is a company established in 1998, based on the RIKEN Venture System of the National Research and Development Agency RIKEN, with Yoshihide Hayasaki from RIKEN (who has been the representative director of Danaform Inc. since 2021) at its core. The company is actively engaged in gene analysis and genetic testing, focusing on technologies co-developed by Danaform and RIKEN, including contract analysis using next-generation sequencers such as CAGE-seq and RNA-seq, the sale of fluorescent reagents Eprobe capable of SNP detection, and the sale of various clones, boasting a significant inventory. Moving forward, we aim to refine our proprietary technologies and strive for higher quality research and manufacturing as experts in the field of genetics, with the hope of contributing to people's health.
